Dr. Kevin Schwartzman
Dr. Kevin Schwartzman is director of the Respiratory Division and Professor of Medicine at McGill University. He is a clinician-investigator at the Montreal Chest Institute and the McGill International TB Centre, with longstanding clinical and research interest in TB. His research has focused on TB epidemiology, and the cost-effectiveness of TB-related interventions in a variety of settings. He is currently Chair of the TB Section of the Union.
Vice-President and Program Chair
Dr. Sarah Brode
Dr. Sarah Brode is a clinician investigator and an assistant professor of medicine at the University of Toronto. She is the Physician Lead of the Tuberculosis Program at West Park Healthcare Centre, and is also a staff Respirologist and a clinician in the NTM program at Toronto Western Hospital (University Health Network), in Toronto, Canada. Her research focuses on epidemiology, treatment, and outcomes in tuberculosis and nontuberculous mycobacterial disease.
Dr. Jonathan Golub
Dr. Golub is a Professor of Medicine, Epidemiology and International Health at Johns Hopkins University. His research focuses on the epidemiology of tuberculosis in South Africa, Brazil, India and the US, with specific focus on the drivers of TB in these settings, including tobacco use, alcohol abuse, diabetes, HIV-infection, and indoor air pollution. He is also leading implementation studies designed to increase tuberculosis preventive therapy in people living with HIV and children. He also teaches the Epidemiologic Basis for TB Control at the Johns Hopkins Bloomberg School of Public Health.
Dr. Lisa Chen
Lisa Chen is a Professor of Medicine in the division of Pulmonary and Critical Care Medicine at the University of California San Francisco. She heads the Curry International TB Center at UCSF, which serves as a CDC center of excellence for TB training, education and consultation for the US. As a clinician, educator and advisor, Lisa has supported the San Francisco TB control program for over 20 years in varying roles, including as former medical director of the Tenderloin Outreach Program for at-risk urban populations. Her international focus for over 15 years has been primarily as a technical advisor to national TB programs in Tanzania, Uganda and Indonesia helping to launch and strengthen their Drug-resistant TB programs, and as an education specialist leading past training initiatives for the International Standards of TB Care. She is the Senior Director for the global MECOR research training program of the American Thoracic Society and currently is deeply involved in the joint UCSF/UCLA California public health training initiative for Covid-19 case investigation and contact tracing.
Dr. C. Robert Horsburgh, Jr.
Dr Robert Horsburgh is Professor of Epidemiology, Biostatistics, Global Health and Medicine at Boston University. He is an experienced TB clinician and his research has focused on TB clinical and epidemiologic research and clinical trials. He has served as Chairman of the infectious Diseases Society of America’s TB Committee, Chairman of the Steering Committee of the U.S. Tuberculosis Trials Consortium (TBTC), and Chairman of the Steering Committee of the U.S. Tuberculosis Epidemiologic Studies Consortium (TBESC). He is a member of the U.S. Advisory Committee for the Elimination of Tuberculosis (ACET), which advises CDC on tuberculosis control and elimination strategy. In addition, he is Co-Chairman of the Drug-Resistance Working Group of the IUATLD, Chair of the MDR/XDR-TB Working Group of the TBTC, and Chairman of the Steering Committee of Research Excellence to Stop TB Resistance (RESIST-TB), an international organization that advocates for clinical trials of Drug-resistant TB treatment (http://www.resisttb.org/).
Immediate Past Vice-President and Program Chair
Dr. Lisa V. Adams
Dr. Lisa V. Adams is the Associate Dean for Global Health, an Associate Professor of Medicine in the Section of Infectious Disease and International Health and Director of the Center for Global Health Equity at Dartmouth’s Geisel School of Medicine. In all her roles, she develops and oversees interdisciplinary global health programs involving faculty and students. She has worked in domestic and international TB care and prevention for over 25 years with expertise in pediatric TB, TB program monitoring and evaluation, and person-centered TB care delivery. She is the former Director of Surveillance for the New York City Department of Health’s Bureau of TB Control. As an international TB consultant, she has worked in over a dozen countries to provide technical assistance to Ministries of Health. She has been a co-investigator on several clinical and operations research trials on TB and HIV through the DarDar Programs, a collaboration between Dartmouth and Muhimbili University in Dar es Salaam, Tanzania. She is currently engaged with local partners in Eswatini and Tanzania to improve delivery of TB care services to children and persons living with HIV.
Dr. Menn Biagtan
Menn Biagtan, is the Vice-President, Health Initiatives and Programs of the British Columbia Lung Association overseeing the Association’s lung health initiatives local, national and international projects. In her two decades with the BC Lung Association she has served on numerous committees, working groups and panels to advance lung health. Her main focus is on public health, health policy development particularly in the field of air quality and tobacco. One of her many responsibilities is managing the various activities of the Union-North America Region. She has been organizing the annual conference of The Union-NAR (which today is considered as the premier TB conference in North America) since 1998.
Mr. Christopher Lam
Christopher Lam is the President and CEO of the British Columbia Lung Association, one of Canada’s most highly respected health agencies. Mr. Lam graduated with honours from the School of Communication at Simon Fraser University in Vancouver. He has spent the previous 13 years working for lung health at the Lung Association and has also spent time working for Paramount Pictures Canada. Chris is currently of the Board of Directors of the Alliance for Healthy Living and is also serving on numerous national committees and working groups. Chris has an interest in many areas of public health, health policy development and in particular in air quality and tobacco control, two areas in which the Lung Association is a recognized leader.